WBA - Walgreens Boots Alliance Inc Stock Price, Fair Value and News

18.27USD+0.68 (+3.87%)Market Closed

Market Summary

USD18.27+0.68

Market Closed

3.87%

WBA Alerts

2 major insider buys recently.

Big fall in earnings (Y/Y)
Losses in recent quarter

WBA Stock Price

View Fullscreen

WBA RSI Chart

WBA Valuation

Market Cap

15.8B

Price/Earnings (Trailing)

-2.61

Price/Sales (Trailing)

0.11

EV/EBITDA

-2.01

Price/Free Cashflow

-8.93

WBA Price/Sales (Trailing)

WBA Profitability

EBT Margin

-9.84%

Return on Equity

-39.74%

Return on Assets

-7.17%

Free Cashflow Yield

-11.2%

WBA Fundamentals

WBA Revenue

Revenue (TTM)

144.6B

Rev. Growth (Yr)

6.28%

Rev. Growth (Qtr)

0.94%

WBA Earnings

Earnings (TTM)

-6.0B

Earnings Growth (Yr)

-940.4%

Earnings Growth (Qtr)

-8.7K%

Breaking Down WBA Revenue

Last 7 days

-2.7%

Last 30 days

-15.1%

Last 90 days

-20.0%

Trailing 12 Months

-49.5%

How does WBA drawdown profile look like?

WBA Financial Health

Current Ratio

0.66

Debt/Equity

0.5

Debt/Cashflow

0.01

WBA Investor Care

Dividend Yield

9.25%

Dividend/Share (TTM)

1.68

Shares Dilution (1Y)

0.02%

Diluted EPS (TTM)

-7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	144.6B	0	0	0
2023	133.3B	136.1B	139.1B	142.4B
2022	135.9B	134.5B	132.7B	132.2B
2021	125.0B	128.6B	132.5B	135.0B
2020	129.8B	125.6B	122.0B	123.5B
2019	136.1B	136.4B	136.9B	133.0B
2018	124.0B	128.2B	131.5B	134.6B
2017	116.1B	116.7B	118.2B	120.5B
2016	116.5B	117.2B	117.4B	116.8B
2015	84.6B	94.0B	103.4B	112.9B
2014	74.3B	75.3B	76.4B	77.6B
2013	0	0	72.2B	73.3B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Walgreens Boots Alliance Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 11, 2024	bhandari inderpal s	bought	54,150	18.05	3,000	-
Apr 02, 2024	mahajan manmohan	bought	116,280	19.38	6,000	evp and global cfo
Mar 01, 2024	brown tracey d	acquired	-	-	11,219	evp, pres., walgreens retail
Mar 01, 2024	mahajan manmohan	acquired	-	-	101,874	evp and global cfo
Mar 01, 2024	fabbri beth amber l.	acquired	-	-	14,052	chief corp. affairs officer
Mar 01, 2024	heckman todd	acquired	-	-	12,541	svp, global controller and cao
Jan 29, 2024	jarrett valerie b	bought	99,992	22.44	4,456	-
Jan 16, 2024	schlichting nancy m	sold	-350,567	23.05	-15,209	-
Jan 05, 2024	wentworth timothy c	bought	242,220	24.222	10,000	chief executive officer
Nov 10, 2023	gates richard p.	sold	-20,450	20.45	-1,000	svp, chief pharmacy officer

Which funds bought or sold WBA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 18, 2024	Park Place Capital Corp	unchanged	-	-2,172	10,664	-%
Apr 18, 2024	Eagle Ridge Investment Management	unchanged	-	-204,646	1,004,250	0.09%
Apr 18, 2024	WOLFF WIESE MAGANA LLC	unchanged	-	-119	586	-%
Apr 18, 2024	BKM Wealth Management, LLC	sold off	-100	-44,291	-	-%
Apr 18, 2024	SteelPeak Wealth, LLC	added	93.32	2,841,620	7,531,030	0.38%
Apr 18, 2024	HALBERT HARGROVE GLOBAL ADVISORS, LLC	reduced	-0.2	-114,926	557,433	0.04%
Apr 18, 2024	Capital Advisors, Ltd. LLC	reduced	-1.22	-3,000	10,000	-%
Apr 18, 2024	MV CAPITAL MANAGEMENT, INC.	added	44.96	5,183	30,562	-%
Apr 18, 2024	Hexagon Capital Partners LLC	reduced	-19.27	-96,404	196,334	0.04%
Apr 18, 2024	tru Independence LLC	reduced	-9.9	-568,799	1,692,250	0.50%

Are Funds Buying or Selling WBA?

Are funds buying WBA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own WBA

No. of Funds

Unveiling Walgreens Boots Alliance Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.62%	83,138,208	SC 13G/A
Jan 29, 2024	state street corp	6.28%	54,285,227	SC 13G/A
Jan 26, 2024	blackrock inc.	7.6%	65,892,675	SC 13G/A
Oct 10, 2023	vanguard group inc	10.04%	86,673,303	SC 13G/A
Feb 09, 2023	vanguard group inc	7.13%	61,519,967	SC 13G/A
Feb 07, 2023	state street corp	6.68%	57,573,619	SC 13G/A
Jan 31, 2023	blackrock inc.	7.0%	60,606,871	SC 13G/A
Feb 14, 2022	state street corp	5.45%	47,095,044	SC 13G/A
Feb 07, 2022	blackrock inc.	6.4%	55,032,519	SC 13G/A
Feb 11, 2021	state street corp	5.43%	46,922,371	SC 13G

Recent SEC filings of Walgreens Boots Alliance Inc

View All Filings

Date Filed	Form Type	Document
Apr 15, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Mar 28, 2024	10-Q	Quarterly Report
Mar 28, 2024	3	Insider Trading
Mar 28, 2024	8-K	Current Report
Mar 28, 2024	8-K	Current Report
Mar 15, 2024	3	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading

Peers (Alternatives to Walgreens Boots Alliance Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	356.3B	85.2B	-6.70%	-10.33%	10.14	4.18	6.46%	95.94%
MRK	318.7B	60.1B	2.45%	9.70%	873.24	5.3	1.40%	-97.49%
PFE	146.8B	46.5B	-8.14%	-36.93%	-105.7	3.15	42.59%	-114.62%
AMGN	144.1B	28.2B	-3.32%	6.70%	21.46	5.11	7.09%	2.52%
GILD	83.2B	27.1B	-9.93%	-21.39%	14.68	3.07	-0.60%	23.36%
TEVA	14.4B	15.8B	-4.27%	50.53%	-25	0.91	6.17%	76.47%
MID-CAP
PRGO	4.1B	4.7B	-0.96%	-17.31%	-319.48	0.87	4.58%	90.97%
ALKS	4.0B	1.7B	-14.12%	-18.81%	11.16	2.39	49.61%	324.78%
BHC	3.1B	8.8B	-9.85%	14.21%	-5.31	0.36	7.79%	-163.11%
AMPH	1.9B	644.4M	-13.30%	-10.60%	13.51	2.88	29.14%	50.51%
SMALL-CAP
TLRY	1.3B	743.2M	-9.90%	-28.22%	-3.8	1.8	24.65%	80.36%
TXMD	21.6M	1.3M	-17.90%	-49.05%	-2.1	16.56	-98.14%	-109.18%
ACRX	17.6M	-	-9.57%	32.48%	-0.96	0.22	2882.68%	-138.52%
AGRX	2.5M	19.6M	-30.19%	-94.45%	-0.18	0.13	80.00%	43.08%
ACOR	472.0K	117.6M	-96.45%	-95.94%	0	0	-0.79%	-283.60%

Walgreens Boots Alliance Inc News

Latest updates

Walgreens Boots Alliance Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	0.9%	37,052	36,707	35,422	35,415	34,862	33,382	32,449	32,597	33,756	33,901	34,262	34,030	32,779	31,438	30,371	30,364	31,336	29,912	33,954	34,591	34,528
Gross Profit	4.0%	7,041	6,771	6,475	6,588	7,055	6,953	6,410	6,572	7,708	7,574	7,503	7,153	6,781	6,630	6,324	5,959	7,017	6,777	7,228	7,453	7,754
S&GA Expenses	15.6%	7,921	6,851	6,990	7,123	6,934	13,158	7,320	7,019	6,565	6,391	6,650	6,116	6,029	5,792	5,577	7,884	5,909	6,262	4,723	6,235	6,320
EBITDA Margin	-553.5%	-0.08*	0.02*	-0.02*	-0.02*	-0.02*	-0.02*	0.05*	0.06*	0.07*	0.07*	0.04*	0.03*	0.01*	0.01*	0.02*	-	-	-	-	-	-
Interest Expenses	39.4%	138	99.00	156	173	141	110	106	108	100	86.00	88.00	545	137	136	147	148	156	166	121	187	181
Income Taxes	-956.8%	-782	-74.00	-151	-330	70.00	-1,447	-235	-242	172	275	586	246	42.00	-207	206	-43.00	149	32.00	15.00	156	226
Earnings Before Taxes	-3563.1%	-13,114	-358	-374	-382	607	-5,270	-758	-18.00	947	3,814	907	749	946	-607	460	-1,862	1,008	882	540	1,198	1,356
EBT Margin	-2661.0%	-0.10*	0.00*	-0.04*	-0.04*	-0.04*	-0.04*	0.03*	0.04*	0.05*	0.05*	0.02*	0.01*	-0.01*	-0.01*	0.00*	-	-	-	-	-	-
Net Income	-8717.9%	-5,908	-67.00	-180	118	703	-3,721	-415	289	883	3,580	627	1,197	1,026	-308	373	-1,708	946	845	677	1,025	1,156
Net Income Margin	-1135.7%	-0.04*	0.00*	-0.02*	-0.02*	-0.02*	-0.02*	0.03*	0.04*	0.05*	0.05*	0.02*	0.02*	0.00*	-0.01*	0.00*	-	-	-	-	-	-
Free Cashflow	-25.7%	-989	-787	555	-545	248	-117	-407	1,258	669	645	867	1,445	1,100	764	1,674	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-13.9%	84,207	97,823	96,628	98,605	100,479	92,875	90,124	92,759	92,683	96,507	81,285	91,920	90,920	89,167	87,174	86,444	90,003	90,807	67,598	68,586	70,434
Current Assets	-4.5%	16,561	17,345	15,503	16,542	17,689	19,523	16,902	18,872	16,824	20,314	15,814	26,607	26,084	21,084	18,073	18,326	18,909	19,604	18,700	19,021	19,851
Cash Equivalents	-14.8%	668	784	739	871	1,993	4,314	2,558	4,541	2,027	4,268	559	1,803	1,311	1,339	746	943	988	1,000	1,207	768	792
Inventory	-9.5%	8,557	9,454	8,257	8,164	8,757	9,322	8,353	8,520	8,947	9,475	8,159	8,333	8,541	11,180	7,917	9,563	9,652	10,536	9,333	9,874	10,188
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,482	13,620	13,478	13,717	13,828
Goodwill	-43.9%	15,814	28,184	28,187	28,371	92.00	22,582	22,280	21,901	21,958	8,166	12,421	12,493	12,468	15,299	12,013	14,948	16,788	16,800	13,542	16,717	-
Liabilities	-1.7%	68,843	70,066	68,140	69,086	70,882	68,137	59,717	61,602	61,004	63,141	57,145	69,014	68,985	68,426	66,038	-	-	-	-	-	-
Current Liabilities	-4.6%	24,915	26,116	24,535	26,170	28,228	28,036	22,583	24,067	22,699	24,447	22,054	34,475	31,246	30,379	27,070	26,649	28,662	29,494	25,769	25,060	25,303
Short Term Borrowings	16.0%	1,937	1,670	917	3,061	4,222	3,938	1,059	2,787	2,105	2,647	1,305	7,963	5,161	5,245	3,265	4,379	5,984	6,225	5,738	5,483	5,356
Long Term Debt	-0.7%	7,535	7,585	8,145	8,841	8,820	7,789	10,615	10,670	11,203	11,199	7,675	7,732	10,998	10,973	12,203	12,111	10,625	10,628	11,098	12,127	12,685
LT Debt, Non Current	-0.7%	7,535	7,585	8,145	8,841	8,820	7,789	10,615	10,670	11,203	11,199	7,675	7,732	10,998	10,973	12,203	12,111	10,625	10,628	11,098	12,127	12,685
Shareholder's Equity	-51.1%	13,484	27,588	20,020	21,063	29,439	24,582	29,366	30,382	30,867	30,579	23,822	22,596	21,625	20,563	21,136	21,323	24,334	24,314	24,152	24,771	25,413
Retained Earnings	-18.8%	26,448	32,573	33,058	33,654	33,952	33,664	37,801	38,632	38,757	38,286	35,121	34,908	34,116	33,495	34,210	34,244	36,351	35,810	35,815	35,547	34,928
Additional Paid-In Capital	0.1%	10,627	10,617	10,661	10,667	10,629	10,477	10,950	11,029	10,973	10,966	10,988	10,971	10,916	10,876	10,761	10,726	10,689	10,648	10,639	10,605	10,571
Shares Outstanding	0.0%	863	863	863	863	863	864	864	864	864	866	865	-	865	865	879	-	-	-	-	-	-
Minority Interest	-78.9%	1,708	8,107	8,302	8,296	8,247	4,006	4,091	-	-	4,316	402	495	514	506	498	586	615	653	641	638	643
Float	-	-	-	-	-	25,400	-	23,200	-	-	-	-	-	23,200	-	-	-	33,500	-	-	-	54,500

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-126.7%	-637	-281	1,039	-20.00	746	493	86.00	1,629	1,085	1,099	1,245	1,754	1,361	1,195	2,086	914	1,423	1,061	2,379	2,020	735
Share Based Compensation	-5.9%	48.00	51.00	37.00	55.00	71.00	222	125	96.00	135	35.00	35.00	50.00	34.00	36.00	36.00	34.00	39.00	28.00	32.00	24.00	36.00
Cashflow From Investing	861.2%	817	85.00	155	334	-5,441	1,858	198	919	-223	-1,958	5,413	15.00	-1,097	-259	-637	-43.00	-215	-402	-738	-523	-411
Cashflow From Financing	-268.3%	-313	186	-1,460	-1,193	2,365	-599	-2,252	-16.00	-3,108	3,877	-7,180	-1,209	-295	-352	-1,649	-913	-1,219	-866	-1,474	-1,458	-505
Dividend Payments	-0.5%	413	415	415	415	414	415	408	418	420	413	405	404	403	405	487	403	447	410	399	403	419
Buy Backs	-100.0%	-	69.00	-	-	-	150	-	-	33.00	154	-	-	-	110	215	461	440	473	434	613	2,201

WBA Income Statement

2024-02-29

CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Income Statement [Abstract]
Sales	$ 37,052	$ 34,862	$ 73,760	$ 68,244
Cost of sales	30,012	27,807	59,948	54,236
Gross profit	7,041	7,055	13,811	14,008
Selling, general and administrative expenses	7,921	6,934	14,772	20,091
Impairments	12,369	0	12,369	0
Equity earnings in Cencora	79	75	120	129
Operating (loss) income	(13,171)	197	(13,209)	(5,954)
Other income (expense), net	195	552	(25)	1,544
(Loss) earnings before interest and income tax (benefit) provision	(12,976)	749	(13,235)	(4,410)
Interest expense, net	138	141	237	252
(Loss) earnings before income tax (benefit) provision	(13,114)	607	(13,472)	(4,662)
Income tax (benefit) provision	(782)	70	(856)	(1,377)
Post-tax earnings from other equity method investments	10	6	16	13
Net (loss) earnings	(12,322)	544	(12,600)	(3,272)
Net loss attributable to non-controlling interests	(6,415)	(159)	(6,625)	(253)
Net (loss) earnings attributable to Walgreens Boots Alliance, Inc.	$ (5,908)	$ 703	$ (5,975)	$ (3,018)
Earnings Per Share, Basic [Abstract]
Total (in dollars per share)	$ (6.85)	$ 0.81	$ (6.93)	$ (3.50)
Earnings Per Share, Diluted [Abstract]
Total (in dollars per share)	$ (6.85)	$ 0.81	$ (6.93)	$ (3.50)
Weighted average common shares outstanding:
Basic (in shares)	862.5	862.6	862.8	863.1
Diluted (in shares)	862.5	863.4	862.8	863.1

WBA Balance Sheet

2024-02-29

CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($) $ in Millions	Feb. 29, 2024	Aug. 31, 2023
Current assets:
Cash and cash equivalents	$ 668	$ 739
Accounts receivable, net	6,200	5,381
Inventories	8,557	8,257
Other current assets	1,136	1,127
Total current assets	16,561	15,503
Non-current assets:
Property, plant and equipment, net	10,121	11,587
Operating lease right-of-use assets	21,342	21,667
Goodwill	15,814	28,187
Intangible assets, net	12,984	13,635
Equity method investments (see Note 5)	3,256	3,497
Other non-current assets	4,128	2,550
Total non-current assets	67,646	81,125
Total assets	84,207	96,628
Current liabilities:
Short-term debt	1,937	917
Trade accounts payable (see Note 16)	12,775	12,635
Operating lease obligations	2,339	2,347
Accrued expenses and other liabilities	7,522	8,426
Income taxes	342	209
Total current liabilities	24,915	24,535
Non-current liabilities:
Long-term debt	7,535	8,145
Operating lease obligations	21,812	22,124
Deferred income taxes	1,238	1,318
Accrued litigation obligations	6,123	6,261
Other non-current liabilities	7,220	5,757
Total non-current liabilities	43,928	43,605
Commitments and contingencies (see Note 10)
Total liabilities	68,843	68,140
Redeemable non-controlling interests	172	167
Equity:
Preferred stock $.01 par value; authorized 32 million shares, none issued	0	0
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at February 29, 2024 and August 31, 2023	12	12
Paid-in capital	10,627	10,661
Retained earnings	26,448	33,058
Accumulated other comprehensive loss	(2,897)	(2,993)
Treasury stock, at cost; 309,800,252 shares at February 29, 2024 and 308,839,832 shares at August 31, 2023	(20,705)	(20,717)
Total Walgreens Boots Alliance, Inc. shareholders’ equity	13,484	20,020
Non-controlling interests	1,708	8,302
Total equity	15,192	28,322
Total liabilities, redeemable non-controlling interests and equity	$ 84,207	$ 96,628

About Walgreens Boots Alliance Inc

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

CEO	Ms. Ginger L. Graham
WEBSITE	walgreensbootsalliance.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	65535

Walgreens Boots Alliance Inc Frequently Asked Questions

What is the ticker symbol for Walgreens Boots Alliance Inc? What does WBA stand for in stocks?

WBA is the stock ticker symbol of Walgreens Boots Alliance Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Walgreens Boots Alliance Inc (WBA)?

As of Thu Apr 18 2024, market cap of Walgreens Boots Alliance Inc is 15.18 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of WBA stock?

You can check WBA's fair value in chart for subscribers.

What is the fair value of WBA stock?

You can check WBA's fair value in chart for subscribers. The fair value of Walgreens Boots Alliance Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Walgreens Boots Alliance Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for WBA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Walgreens Boots Alliance Inc a good stock to buy?

The fair value guage provides a quick view whether WBA is over valued or under valued. Whether Walgreens Boots Alliance Inc is cheap or expensive depends on the assumptions which impact Walgreens Boots Alliance Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for WBA.

What is Walgreens Boots Alliance Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, WBA's PE ratio (Price to Earnings) is -2.51 and Price to Sales (PS) ratio is 0.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. WBA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Walgreens Boots Alliance Inc's stock?

In the past 10 years, Walgreens Boots Alliance Inc has provided -0.102 (multiply by 100 for percentage) rate of return.